百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06160 百济神州

已收盘 03-24 16:08:20

166.600

+4.700

+2.90%

最高167.500	最低162.200	成交量257.27万
今开165.400	昨收161.900	日振幅3.27%
总市值2,567亿	流通市值2,376亿	总股本15.41亿
成交额4.24亿	换手率0.18%	流通股本14.26亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06160","market":"HK","secType":"STK","nameCN":"百济神州","latestPrice":166.6,"timestamp":1774339700006,"preClose":161.9,"halted":0,"volume":2572676,"delay":0,"changeRate":0.02903026559604687,"floatShares":1426000000,"shares":1541000000,"eps":1.4871867123780897,"marketStatus":"已收盘","change":4.7,"latestTime":"03-24 16:08:20","open":165.4,"high":167.5,"low":162.2,"amount":424331975,"amplitude":0.032736,"askPrice":166.6,"askSize":88000,"bidPrice":166.5,"bidSize":9000,"shortable":3,"etf":0,"ttmEps":1.4871867123780897,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774402200000},"marketStatusCode":5,"adr":0,"listingDate":1533657600000,"exchange":"SEHK","adjPreClose":161.9,"openAndCloseTimeList":[[1774315800000,1774324800000],[1774328400000,1774339200000]],"volumeRatio":0.712035,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","optionSymbol":"BOM.HK","astockBrief":{"symbol":"688235","market":"SH","secType":"STK","nameCN":"百济神州","latestPrice":221.11,"timestamp":1774335600000,"preClose":215.51,"halted":0,"volume":3817000,"delay":0,"premium":"-33.62"},"impliedVol":0.419,"impliedVolPercentile":0.7273},"requestUrl":"/m/hq/s/06160","defaultTab":"news","newsList":[{"id":"2621768777","title":"百济神州跌5.30%，浦银国际证券二周前给出“买入”评级，目标价236.00元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621768777","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621768777?lang=zh_cn&edition=full","pubTime":"2026-03-23 16:36","pubTimestamp":1774255005,"startTime":"0","endTime":"0","summary":"今日百济神州跌5.30%，收盘报215.51元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，研报发布时股价为238.49元，预期涨幅为1.04%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的甘坛焕。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032300025277.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688235","161027","06160"],"gpt_icon":0},{"id":"2621095723","title":"【券商聚焦】交银国际：CXO行情持续回暖 料板块估值倍数合理","url":"https://stock-news.laohu8.com/highlight/detail?id=2621095723","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621095723?lang=zh_cn&edition=full","pubTime":"2026-03-23 10:25","pubTimestamp":1774232735,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，多重利好因素共振下，2025年以来CXO行情持续回暖。该机构建议重点关注标的细分赛道成长力、核心能力布局、盈利和订单增长能见度、地缘风险敞口及估值上升空间。基于此，该机构首推药明合联，首次覆盖并重点推荐凯莱英和康龙化成。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZDQ3YWRiNzU2MjI5OWUwYTllMmZlMTAyNzEyNzQzMTU2MQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1977006","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","LU0540923850.HKD","IE00B543WZ88.USD","BK1593","LU1770034418.SGD","09926","LU0307460666.USD","LU0348767384.USD","LU2399975544.HKD","BK1583","LU2476274308.USD","CXO","LU0417516902.SGD","LU0634319403.HKD","LU0348784397.USD","LU1719994722.HKD","LU2328871848.SGD","02367","BK1585","BK1588","BK1197","BK1500","06160","IE00BPRC5H50.USD","03933","09688","LU0348766576.USD","LU0417516571.SGD","BK1191","01789","BK1207","LU0348735423.USD","06821","LU2778985437.USD","LU1115378108.SGD","LU0348827113.USD","02228","LU2488822045.USD","LU1794554557.SGD","01530","BK1141","LU0417516738.SGD","BK1574","03329","02196","BK1617","LU1303224171.USD","01099","02268","LU2476274720.SGD"],"gpt_icon":0},{"id":"2620203185","title":"【券商聚焦】中国银河：“十五五”首次将生物医药列为国家新兴支柱产业，持续发力研发创新","url":"https://stock-news.laohu8.com/highlight/detail?id=2620203185","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620203185?lang=zh_cn&edition=full","pubTime":"2026-03-20 09:23","pubTimestamp":1773969824,"startTime":"0","endTime":"0","summary":"“十四五”规划重点关注医药创新产品产业化、医药产业化技术攻关、疫苗和短缺药品供应保障、产品质量升级、医药工业绿色低碳等五大工程，成效斐然，中国创新药获批上市数量由2015年的11款提升至2024年的92款，2024年共有22款国产化药和17款国产生物药获批上市，国产创新药占比提升至42%。“十五五”规划提出健全医疗、医保、医药协同发展和治理机制，生物医药产业首次被列为国家“新兴支柱产业”，战略定位进一步提升。","market":"other","thumbnail":"https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/ODJmOWY1ZDhkZDY4MmEzZDMyMTcwNTE1ODgyMzc=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1976888","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0561508036.HKD","LU0708995583.HKD","SG9999014674.SGD","BK4585","LU1969619763.USD","02359","06881","02268","399441","LU0417516571.SGD","LU0307460666.USD","LU0348767384.USD","06990","LU1770034418.SGD","LU2778985437.USD","HK0000306685.HKD","XBI","LU0052750758.USD","HK0000320223.HKD","LU2242644610.SGD","LU2476274720.SGD","BK1147","BK1161","BK4581","BK1588","IE00B543WZ88.USD","LU2125910500.SGD","LU0348825331.USD","02696","LU0348766576.USD","BK4588","601881","BK1564","LU2328871848.SGD","LU0348735423.USD","LU2476274308.USD","09995","LU0540923850.HKD","09926","HK0000306701.USD","BK1141","06160","161726","LU2045819591.USD","LU0196878994.USD","LU0588546209.SGD","LU1720050803.USD","02162","BK0276"],"gpt_icon":0},{"id":"2619127643","title":"每周股票复盘：百济神州（688235）员工购股计划新一期启动","url":"https://stock-news.laohu8.com/highlight/detail?id=2619127643","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619127643?lang=zh_cn&edition=full","pubTime":"2026-03-15 01:12","pubTimestamp":1773508333,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，百济神州报收于228.68元，较上周的238.49元下跌4.11%。公司公告汇总港股公告：员工购股计划百济神州有限公司根据上市规则第17.06A、17.06B及17.06C条公告2018员工购股计划新一轮认购期。港股公告：翌日披露报表百济神州有限公司于2026年3月11日因执行第五版经修订及重列之2018员工购股权计划，向参与人发行741,299股普通股，每股发行价为162.08港元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000095.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06160","LU1251922891.USD","LU1719994722.HKD","688235","BK1588","LU0307460666.USD","LU1969619763.USD","BK1583","LU1770034418.SGD","BK1161","BK1500","LU1303224171.USD","BK0239","LU0588546209.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2618387191","title":"百济神州：合共5.7万股美国存托股份获购买","url":"https://stock-news.laohu8.com/highlight/detail?id=2618387191","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618387191?lang=zh_cn&edition=full","pubTime":"2026-03-12 18:00","pubTimestamp":1773309618,"startTime":"0","endTime":"0","summary":"智通财经讯，百济神州(06160)发布公告，截至2025年9月2日至2026年2月27日之认购期的最后一日，合共5.7万股美国存托股份由4431名参与者根据2018员工购股计划购买。所购美国存托股份涉及的股份数目为74.13万，代表于本公告之日本公司已发行股份总数的约0.05%。本文源自：智通财经网","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312180411954a3586&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312180411954a3586&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU1303224171.USD","LU1969619763.USD","BK1583","LU0588546209.SGD","BK1500","BK1161","LU0307460666.USD","LU1770034418.SGD","BK1588","LU1719994722.HKD","LU2328871848.SGD","LU1251922891.USD"],"gpt_icon":0},{"id":"2618138715","title":"每日卖空追踪 | 百济神州 03月12日卖空量成交65.68万股，卖空比例为12.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618138715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618138715?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:30","pubTimestamp":1773304238,"startTime":"0","endTime":"0","summary":"百济神州北京时间03月12日，跌1.45%，卖空量成交65.68万股，较上一交易日增加6.11%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163548a4637616&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260312163548a4637616&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1500","LU0307460666.USD","BK1588","LU1770034418.SGD","BK1161","LU1303224171.USD","LU0588546209.SGD","LU1251922891.USD","LU1969619763.USD","LU2328871848.SGD","06160","BK1583","LU1719994722.HKD"],"gpt_icon":0},{"id":"2618972362","title":"百济神州(06160)根据股份计划发行74.13万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2618972362","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618972362?lang=zh_cn&edition=full","pubTime":"2026-03-12 07:44","pubTimestamp":1773272679,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，于2026年3月11日根据股份计划发行74.13万股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","LU1719994722.HKD","LU1303224171.USD","06160","LU1969619763.USD","BK4588","ONC","BK4526","LU0588546209.SGD","LU0307460666.USD","LU1251922891.USD","BK0239","LU1770034418.SGD","BK1588","BK1583","688235","BK4139","BK1500","LU2328871848.SGD","BK4585"],"gpt_icon":0},{"id":"1155644696","title":"百济神州（06160）更新翌日披露报表，发行741,299股新股占比约0.048%","url":"https://stock-news.laohu8.com/highlight/detail?id=1155644696","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1155644696?lang=zh_cn&edition=full","pubTime":"2026-03-12 07:40","pubTimestamp":1773272447,"startTime":"0","endTime":"0","summary":"百济神州有限公司（根据瑞士法律注册成立的公司，股票代码：06160）于2026年3月12日发布翌日披露报表。公告显示，公司于2026年3月11日根据第五版经修订及重列之2018员工购股权计划，发行普通股741,299股，占发行前已发行股本约0.048%，每股发行价为港币162.08。发行完成后，公司已发行股本增至1,426,363,848股，库藏股数量保持为零。\n同时，公司在上海证券交易所科创板上市的人民币股份（股份代号：688235）维持115,055,260股，未发生变动。公告亦确认本次股份发行遵守相关上市规则及法律程序，且已获得适当授权。\n该公告由执行董事、主席兼首席执行官欧雷强签署。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06160"],"gpt_icon":0},{"id":"2618231069","title":"百济神州（688235）披露港股审计委员会将审议2025年全年业绩，3月11日股价下跌2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618231069","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618231069?lang=zh_cn&edition=full","pubTime":"2026-03-11 22:10","pubTimestamp":1773238231,"startTime":"0","endTime":"0","summary":"截至2026年3月11日收盘，百济神州报收于238.09元，较前一交易日下跌2.9%，最新总市值为3668.2亿元。近日，百济神州有限公司发布港股公告显示，公司董事会审计委员会将于2026年3月25日审议及批准公司及其附属公司截至2025年12月31日止全年业绩，并根据香港上市规则刊发全年业绩。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031100039170.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","LU1770034418.SGD","LU1719994722.HKD","LU2328871848.SGD","06160","LU0588546209.SGD","LU1969619763.USD","BK1583","LU1251922891.USD","BK0239","688235","BK1588","LU1303224171.USD","LU0307460666.USD","BK1500"],"gpt_icon":0},{"id":"2618917443","title":"科创板成长层首批“退层”企业出炉！百济神州、寒武纪等在列","url":"https://stock-news.laohu8.com/highlight/detail?id=2618917443","media":"东方财富网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618917443?lang=zh_cn&edition=full","pubTime":"2026-03-11 16:40","pubTimestamp":1773218438,"startTime":"0","endTime":"0","summary":"据统计，截至3月11日，科创板全体公司均以业绩快报或预告形式完成对2025年经营情况的披露，预计将实现营业收入1.59万亿元，同比增长10.3%；净利润591亿元，同比增长28.2%。随着业绩的集中披露，科创板成长层也将迎来首批“退层”公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1345,202603113668838022.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"east_money_stock","symbols":["BK4526","LU2778985437.USD","ONC","LU1969619763.USD","SG9999001051.SGD","LU2476274720.SGD","LU2476274308.USD","BK4585","06160","BK1583","SGXZ81163826.USD","BK1500","BK4588","SGXZ90724238.SGD","LU1719994722.HKD","LU0307460666.USD","BK4139","BK0239","BK1588","SG9999002950.SGD","LU0588546209.SGD","688256","159982","BK0231","SG9999001093.SGD","BK1161","LU1251922891.USD","SG9999003461.SGD","LU2328871848.SGD","SG9999006597.SGD","SG9999001069.SGD","LU1770034418.SGD","LU1303224171.USD","SGXZ49509284.SGD","688235"],"gpt_icon":0},{"id":"2618992379","title":"寒武纪等6家企业将退出科创成长层","url":"https://stock-news.laohu8.com/highlight/detail?id=2618992379","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618992379?lang=zh_cn&edition=full","pubTime":"2026-03-10 20:17","pubTimestamp":1773145028,"startTime":"0","endTime":"0","summary":"6家企业即将退层梳理来看，首批退层企业分布在创新药、高端医疗器械、半导体、人工智能等多个关键领域。科创成长层作为改革核心举措之一，正式起航。同年10月底，科创成长层首批新注册企业上市仪式在上交所举行，禾元生物、西安奕材、必贝特三家公司登陆科创板，成为科创成长层首批新注册公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310202320a6b57820&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310202320a6b57820&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1588","LU1770034418.SGD","BK1583","LU0307460666.USD","06160","LU0588546209.SGD","LU1969619763.USD","LU1303224171.USD","BK1500","BK1161","LU1719994722.HKD","LU2328871848.SGD","LU1251922891.USD"],"gpt_icon":0},{"id":"2618293810","title":"百济神州(06160)：2018 员工购股计划的新一轮认购期自3月2日起至8月31日止","url":"https://stock-news.laohu8.com/highlight/detail?id=2618293810","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618293810?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:53","pubTimestamp":1773132798,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布公告，2018 员工购股计划的新一轮认购期自2026年3月2日起至2026年8月31日止。2018员工购股计划使合资格雇员可按市价15%折让申购股份。雇员可于认购期结束后购买股份，购股资金可从其认购期内所得薪金中扣除。本公司相信，持续为本公司雇员提供通过参与2018员工购股计划获得本公司所有权权益的机会，鼓励其继续受雇于本公司，并使其利益与本公司股东的利益更紧密地保持一致，符合本公司及股东的最佳利益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1412144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0588546209.SGD","BK4588","LU1719994722.HKD","BK4585","ONC","LU2328871848.SGD","688235","BK4139","BK0239","BK1588","BK1161","LU1251922891.USD","BK4526","LU1969619763.USD","LU0307460666.USD","BK1500","BK1583","LU1770034418.SGD","LU1303224171.USD","06160"],"gpt_icon":0},{"id":"2618536980","title":"百济神州涨5.29%，浦银国际证券一日前给出“买入”评级，目前股价已超目标价","url":"https://stock-news.laohu8.com/highlight/detail?id=2618536980","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618536980?lang=zh_cn&edition=full","pubTime":"2026-03-10 16:21","pubTimestamp":1773130864,"startTime":"0","endTime":"0","summary":"今日百济神州涨5.29%，收盘报245.2元。2026年3月9日，浦银国际证券研究员阳景,胡泽宇发布了对百济神州的研报《四季度收入符合预期，2026年催化剂丰富》，该研报对百济神州给出“买入”评级，认为其目标价为236.0元，现价已超分析师预估，涨幅达到3.90%。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为12.74%。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中信证券的甘坛焕。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031000024248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","06160","688235"],"gpt_icon":0},{"id":"2618987777","title":"医药公司财报 | 百济神州⑥：第二大单品替雷利珠单抗的商业化和研发情况","url":"https://stock-news.laohu8.com/highlight/detail?id=2618987777","media":"投行小象","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618987777?lang=zh_cn&edition=full","pubTime":"2026-03-10 15:02","pubTimestamp":1773126161,"startTime":"0","endTime":"0","summary":"百济神州第二大单品替雷利珠单抗2025年全球销售额7.37亿美元，增长19%。商业化情况替雷利珠单抗已在全球多个地区获批上市多种适应症。研发情况截至2025年底，公司已在超过33个国家和地区开展了替雷利珠单抗单药治疗或联合治疗的临床试验，入组超过15,800例受试者，其中超过5,000例受试者来自于中国以外地区。基于这些数据，公司计划向FDA递交替雷利珠单抗的补充生BLA，并向NMPA药品审评中心CDE递交雷利珠单抗和泽尼达妥单抗的补充BLA。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310151121a6b491f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260310151121a6b491f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160"],"gpt_icon":0},{"id":"2618987088","title":"百济神州盘中异动 早盘快速上涨3.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618987088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618987088?lang=zh_cn&edition=full","pubTime":"2026-03-10 09:37","pubTimestamp":1773106631,"startTime":"0","endTime":"0","summary":"2026年03月10日早盘09时37分，百济神州股票出现异动，股价急速拉升3.07%。截至发稿，该股报184.400港元/股，成交量41.5747万股，换手率0.03%，振幅1.79%。机构评级方面，在所有14家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。百济神州股票所在的生物技术行业中，整体涨幅为1.93%。百济神州公司简介：百济神州是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009371197ab75ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026031009371197ab75ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06160","LU1251922891.USD","LU1719994722.HKD","BK1588","LU0307460666.USD","LU1969619763.USD","BK1583","LU1770034418.SGD","BK1161","BK1500","LU1303224171.USD","LU0588546209.SGD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2618987716","title":"每日卖空追踪 | 百济神州 03月09日卖空量成交66.9万股，卖空比例为13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618987716","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618987716?lang=zh_cn&edition=full","pubTime":"2026-03-09 16:30","pubTimestamp":1773045037,"startTime":"0","endTime":"0","summary":"百济神州北京时间03月09日，跌1.87%，卖空量成交66.9万股，较上一交易日减少41.83%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163552a45ae9ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309163552a45ae9ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1303224171.USD","LU1969619763.USD","BK1583","LU1251922891.USD","LU0588546209.SGD","LU1770034418.SGD","LU2328871848.SGD","LU1719994722.HKD","LU0307460666.USD","BK1588","BK1161","BK1500","06160"],"gpt_icon":0},{"id":"2618009613","title":"营收382亿！创新药“一哥”百济神州，全面扭亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2618009613","media":"蓝鲸财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618009613?lang=zh_cn&edition=full","pubTime":"2026-03-09 10:37","pubTimestamp":1773023833,"startTime":"0","endTime":"0","summary":"2月26日晚，百济神州发布2025年业绩快报。然而，面对业绩全面扭亏，市场反应冷淡。财报发布后，百济神州美股两个交易日跌幅超10%。业绩快报显示，百济神州产品收入377.70亿元，同比增长39.9%，主要由百悦泽、安进授权产品及百泽安销售增长驱动。具体来看，2025年百悦泽全球销售额280.67亿元，同比增长48.8%，创历史新高；百泽安全球销售额52.97亿元，同比增长18.6%。随着适应症持续拓展，百济神州已具备头部药企竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.lanjinger.com/d/1772409403580961090","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"lanjinger_stock","symbols":["06978","06160","159992","688235","ONC"],"gpt_icon":0},{"id":"2618118576","title":"恒瑞医药、百济神州快跑，多药企多点开花！中国创新药矩阵持续扩容","url":"https://stock-news.laohu8.com/highlight/detail?id=2618118576","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618118576?lang=zh_cn&edition=full","pubTime":"2026-03-09 10:27","pubTimestamp":1773023252,"startTime":"0","endTime":"0","summary":"在新药上市方面，恒瑞医药坚持差异化研发策略，以临床需求为导向，利用技术平台打造差异化创新产品矩阵，已经有20多个1类创新药获批上市。2025年上半年，公司创新药销售及许可收入95.61亿元，占公司营业收入比重60.66%。据悉，百济神州不断扩大百泽安的全球市场，持续拓展其适应症和报销覆盖，百泽安目前已在全球超过50个市场获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603091102039545a61e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202603091102039545a61e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0588546209.SGD","BK1583","LU0359201885.HKD","06160","BK1574","LU0359202008.SGD","BK1191","LU2328871848.SGD","BK1588","BK1500","LU0307460666.USD","LU1719994722.HKD","LU1770034418.SGD","LU1969619763.USD","LU1023057109.AUD","LU1251922891.USD","BK1161","LU1303224171.USD","LU2543165471.USD","LU0359201612.USD","01276","06978"],"gpt_icon":0},{"id":"2618611852","title":"百济神州盘中异动 快速下跌4.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618611852","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618611852?lang=zh_cn&edition=full","pubTime":"2026-03-09 09:31","pubTimestamp":1773019875,"startTime":"0","endTime":"0","summary":"2026年03月09日早盘09时31分，百济神州股票出现波动，股价急速下跌4.61%。截至发稿，该股报173.900港元/股，成交量12.64万股，换手率0.01%，振幅1.65%。机构评级方面，在所有15家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。百济神州股票所在的生物技术行业中，整体跌幅为1.93%。百济神州公司简介：百济神州是一家全球性、商业阶段的生物科技公司,专注于研究、开发、生产以及商业化创新型药物。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093115a6b082ae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260309093115a6b082ae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1303224171.USD","LU0588546209.SGD","06160","LU1719994722.HKD","BK1500","BK1161","LU1969619763.USD","BK1588","LU0307460666.USD","BK1583","LU1770034418.SGD","LU1251922891.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2617666539","title":"百济神州授出合共2.12万股美国存托股份受限制股份单位","url":"https://stock-news.laohu8.com/highlight/detail?id=2617666539","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617666539?lang=zh_cn&edition=full","pubTime":"2026-03-08 10:31","pubTimestamp":1772937060,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　百济神州（06160）发布公告，于2026年3月2日，董事会薪酬委员会根据2016期权及激励计划的条款授予180名承授人合共2.12万股美国存托股份受限制股份单位。该等受限制股份单位相当于27.56万股股份，约占本公告的日公司发行股份总数的0.02%。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2026-03-08/doc-inhqfsut4635660.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","ONC","LU1719994722.HKD","BK1588","BK1583","BK4139","BK4526","LU1969619763.USD","BK4588","LU1251922891.USD","BK1500","LU1770034418.SGD","LU0588546209.SGD","BK0239","LU1303224171.USD","688235","LU2328871848.SGD","LU0307460666.USD","BK4585","06160"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.beonemedicines.com","stockEarnings":[{"period":"1week","weight":-0.0738},{"period":"1month","weight":-0.2449},{"period":"3month","weight":-0.1201},{"period":"6month","weight":-0.1769},{"period":"1year","weight":0.0412},{"period":"ytd","weight":-0.097}],"compareEarnings":[{"period":"1week","weight":-0.0562},{"period":"1month","weight":-0.0769},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.0806},{"period":"1year","weight":0.0292},{"period":"ytd","weight":-0.0487}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"BeOne Medicines AG（原名：BeiGene Ltd）是一家全球肿瘤学公司，致力于为全球癌症患者研发新疗法。该公司产品组合涵盖血液学和实体瘤，致力于开发多样化的新型疗法。其产品包Brukinsa、Tevimbra和Pamiparib。Brukinsa是一种口服的布鲁顿酪氨酸激酶(BTK)小分子抑制剂。Tevimbra是一种人源化免疫球蛋白G4（IgG4）抗程序性细胞死亡蛋白1（PD-1）单克隆抗体，具有高亲和力和对PD-1的结合特异性。Tevimbra旨在最大限度地减少与巨噬细胞上Fc-γ（Fcy）受体的结合，帮助人体免疫细胞检测和对抗肿瘤。该公司正在开发的产品线包括Sonrotoclax、Tarlatamab、Zanidatamab、Blinatumomab、BGB-26808、BGB-R046、BG-68501、BG-C9074、BGB-43395、Xaluritamig等。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.027621},{"month":2,"riseRate":0.5,"avgChangeRate":0.032126},{"month":3,"riseRate":0.125,"avgChangeRate":-0.065715},{"month":4,"riseRate":0.428571,"avgChangeRate":0.037509},{"month":5,"riseRate":0.285714,"avgChangeRate":-0.052709},{"month":6,"riseRate":0.428571,"avgChangeRate":0.007027},{"month":7,"riseRate":0.857143,"avgChangeRate":0.097108},{"month":8,"riseRate":0.857143,"avgChangeRate":0.058603},{"month":9,"riseRate":0.5,"avgChangeRate":0.025162},{"month":10,"riseRate":0.5,"avgChangeRate":-0.027038},{"month":11,"riseRate":0.625,"avgChangeRate":0.118183},{"month":12,"riseRate":0.125,"avgChangeRate":-0.07577}],"exchange":"SEHK","name":"百济神州","nameEN":"BEIGENE"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百济神州,06160,百济神州股票,百济神州股票老虎,百济神州股票老虎国际,百济神州行情,百济神州股票行情,百济神州股价,百济神州股市,百济神州股票价格,百济神州股票交易,百济神州股票购买,百济神州股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百济神州(06160)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百济神州(06160)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}